Trioxsalen is 7H-Furo[3,2-g]chromen-7-one in which positions 2, 5, and 9 are substituted by methyl groups. Like other psoralens, trioxsalen causes photosensitization of the skin. It is administered orally in conjunction with UV-A for phototherapy treatment of vitiligo. After photoactivation it creates interstrand cross-links in DNA, inhibiting DNA synthesis and cell division, and can lead to cell injury; recovery from the cell injury may be followed by increased melanisation of the epidermis. Among its listed roles, it functions as a photosensitizing agent and a dermatologic drug. Its therapeutic use is listed as anti-psoriatic agents. The directory classifies it as a commercial API with a natural source/manufacturing origin. Other names for this substance include trioxsalen, Trioxysalen, Trisoralen and Tmp (psoralen). Its PubChem CID is 5585.
Trimethylpsoralen
| CAS No | 3902-71-4 |
|---|---|
| Molecular Formula | C14H12O3 |
| Molecular Weight | 228.24 g/mol |
| Synonyms | 2,5,9-trimethylfuro[3,2-g]chromen-7-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Trioxsalen is 7H-Furo[3,2-g]chromen-7-one in which positions 2, 5, and 9 are substituted by methyl groups. Like other psoralens, trioxsalen causes photosensitization of the skin.
The listed CAS number is 3902-71-4.
The listed molecular formula is C14H12O3.
The listed molecular weight is 228.24 g/mol.
2,5,9-trimethylfuro[3,2-g]chromen-7-one.
The source lists trioxsalen, Trioxysalen, Trisoralen and Tmp (psoralen).